72 related articles for article (PubMed ID: 11875704)
21. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
[TBL] [Abstract][Full Text] [Related]
22. Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
Tropé A; Sjøborg KD; Nygård M; Røysland K; Campbell S; Alfsen GC; Jonassen CM
J Clin Microbiol; 2012 Jun; 50(6):1927-35. PubMed ID: 22518869
[TBL] [Abstract][Full Text] [Related]
23. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
[TBL] [Abstract][Full Text] [Related]
25. Improving the Accuracy and Efficiency of Abnormal Cervical Squamous Cell Detection With Cytologist-in-the-Loop Artificial Intelligence.
Xue P; Xu HM; Tang HP; Weng HY; Wei HM; Wang Z; Zhang HY; Weng Y; Xu L; Li HX; Seery S; Han X; Ye H; Qiao YL; Jiang Y
Mod Pathol; 2023 Aug; 36(8):100186. PubMed ID: 37059230
[TBL] [Abstract][Full Text] [Related]
26. AI-assisted system improves the work efficiency of cytologists via excluding cytology-negative slides and accelerating the slide interpretation.
Du H; Dai W; Zhou Q; Li C; Li SC; Wang C; Tang J; Wu X; Wu R
Front Oncol; 2023; 13():1290112. PubMed ID: 38074680
[TBL] [Abstract][Full Text] [Related]
27. A Task Decomposing and Cell Comparing Method for Cervical Lesion Cell Detection.
Chen T; Zheng W; Ying H; Tan X; Li K; Li X; Chen DZ; Wu J
IEEE Trans Med Imaging; 2022 Sep; 41(9):2432-2442. PubMed ID: 35349436
[TBL] [Abstract][Full Text] [Related]
28. Scientific issues related to the cytology proficiency testing regulations.
Birdsong G; Howell L; Atkison K; Austin RM; Bibbo M; Bonfiglio TA; Davey DD; Keebler C; Mody D; Savaloja L; Papillo J; Prey M; Raab S; Schultz BL; Solomon D
Cytojournal; 2006 Apr; 3():11. PubMed ID: 16620384
[TBL] [Abstract][Full Text] [Related]
29. Corrigendum to "First international proficiency study on human papillomavirus testing in cervical cancer screening" [J Clin Virol. 2023 Oct;167:105581].
Yilmaz E; Eklund C; Lagheden C; Robertsson KD; Lilja M; Elfström M; Mühr LSA; Dillner J
J Clin Virol; 2024 Apr; 171():105660. PubMed ID: 38412680
[No Abstract] [Full Text] [Related]
30. Cervical Cancer Prediction by Merging Features of Different Colposcopic Images and Using Ensemble Classifier.
Nikookar E; Naderi E; Rahnavard A
J Med Signals Sens; 2021; 11(2):67-78. PubMed ID: 34268095
[TBL] [Abstract][Full Text] [Related]
31. A cross-sectional study exploring triage of human papillomavirus (HPV)-positive women by visual assessment, manual and computer-interpreted cytology, and HPV-16/18-45 genotyping in Cameroon.
Vassilakos P; Wisniak A; Catarino R; Tincho Foguem E; Balli C; Saiji E; Tille JC; Kenfack B; Petignat P
Int J Gynecol Cancer; 2021 Jun; 31(6):808-816. PubMed ID: 33833084
[TBL] [Abstract][Full Text] [Related]
32. Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing.
Chrysostomou AC; Stylianou DC; Constantinidou A; Kostrikis LG
Viruses; 2018 Dec; 10(12):. PubMed ID: 30572620
[TBL] [Abstract][Full Text] [Related]
33. Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?
Sahebali S; Depuydt CE; Segers K; Vereecken AJ; Van Marck E; Bogers JJ
J Clin Pathol; 2003 Sep; 56(9):681-6. PubMed ID: 12944552
[TBL] [Abstract][Full Text] [Related]
34. Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing.
Vassilakos P; Petignat P; Boulvain M; Campana A
Br J Cancer; 2002 Feb; 86(3):382-8. PubMed ID: 11875704
[TBL] [Abstract][Full Text] [Related]
35. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
36. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
37. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
[TBL] [Abstract][Full Text] [Related]
38. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
39. DNA Karyometry for Automated Detection of Cancer Cells.
Böcking A; Friedrich D; Schramm M; Palcic B; Erbeznik G
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077750
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
